L
59
4
ETN
65
2
SNA
58
2
KR
50
4
AME
50
3
D
35
2
HCP
56
2
TMO
56
2
FMC
22
2
AVB
55
3
AMZN
63
5
ADT
27
2
INTC
40
3
AIZ
66
3
AMP
50
3
CMS
60
2
SLB
45
4
NTRS
44
5
NWSA
75
8
CRM
67
2
L
59
4
ETN
65
2
SNA
58
2
KR
50
4
AME
50
3
D
35
2
HCP
56
2
TMO
56
2
FMC
22
2
AVB
55
3
AMZN
63
5
ADT
27
2
INTC
40
3
AIZ
66
3
AMP
50
3
CMS
60
2
SLB
45
4
NTRS
44
5
NWSA
75
8
CRM
67
2
Financhill
Back

InfuSystems Holdings 10K Form

Buy
62

INFU
InfuSystems Holdings

Last Price:
$8.20
Seasonality Move:
2.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INFU News And Ratings

See the #1 stock for the next 7 days that we like better than INFU

INFU Financial Statistics

Sales & Book Value

Annual Sales: $125.8M
Cash Flow: $6.4M
Price / Cash Flow: 71.91
Annual Sales: $2.61
Price / Book: 3.14

Profitability

EPS (TTM): 0.06330
Net Income (TTM): $1.5M
Gross Margin: $63.1M
Return on Equity: 2.8%
Return on Assets: 1.42%

InfuSystems Holdings Earnings Forecast

Key InfuSystems Holdings Financial Ratios

  • The Gross Profit Margin over the past 17 years for INFU is 50.17%.
  • The Selling, General & Administrative Expenses for INFU have been equal to 46.14% of Gross Profit Margin.
  • The Interest Expense is 248.85% of Operating Income.
  • The Net Earning history of INFU is 0.69% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 9 years.

InfuSystems Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: INFU
Website: infusystem.com

Debt

Debt-to-Equity Ratio: 0.5
Current Ratio: 1.98
Quick Ratio: 1.37

Price-to-Earnings

Trailing P/E Ratio: 205.25
Forward P/E Ratio: 41.05

INFU Technical Analysis vs Fundamental Analysis

Buy
62
InfuSystems Holdings (INFU) is a Buy

Is InfuSystems Holdings a Buy or a Sell?